Cardiovascular disease risk awareness in systemic lupus erythematosus patients

Lisabeth V Scalzi1, Stanley P Ballou, Jean Y Park

  • 1Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA. lscalzi@hmc.psu.edu

Insights

Physician counseling significantly improves cardiovascular disease (CVD) awareness in patients with systemic lupus erythematosus (SLE). Patients receiving counseling are more likely to recognize SLE as a CVD risk factor and perceive their personal risk.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in systemic lupus erythematosus (SLE) patients.
  • Understanding patient recognition of SLE as an independent CVD risk factor is crucial for preventative strategies.

Purpose of the Study:

  • To identify factors influencing SLE patients' recognition of SLE as an independent CVD risk factor.
  • To assess patient perception of personal CVD risk and the impact of physician counseling.

Main Methods:

  • A questionnaire-based study was conducted with SLE patients assessing demographics, CVD risk factors, and physician counseling received.
  • Logistic regression models were used to analyze variables associated with patient outcomes.

Main Results:

  • 58% of SLE patients reported no CVD counseling from their physicians.
  • Patients who received physician counseling were significantly more likely to recognize SLE as a CVD risk factor (2.3x) and perceive their personal CVD risk (3.2x).
  • Physician counseling was the strongest predictor of perceived CVD risk; younger patients were more likely to recognize SLE as a CVD risk factor.

Conclusions:

  • Physician counseling plays a vital role in enhancing SLE patients' awareness of their CVD risk.
  • Interventions focusing on physician-patient communication regarding CVD risk in SLE are recommended.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...